Escalon Medical Corp.
ESMC · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.01 | -0.13 | -0.00 |
| FCF Yield | 6,905.92% | 0.49% | 2.59% | 32.34% |
| EV / EBITDA | 1.86 | -6.55 | 4.08 | 2.83 |
| Quality | ||||
| ROIC | -9.52% | -15.25% | 9.82% | 10.88% |
| Gross Margin | 41.89% | 43.74% | 46.05% | 48.87% |
| Cash Conversion Ratio | -0.35 | -0.04 | 0.00 | 1.22 |
| Growth | ||||
| Revenue 3-Year CAGR | 498.53% | -0.37% | 2.69% | 3.62% |
| Free Cash Flow Growth | 715,455.56% | -61.30% | -89.80% | 802.94% |
| Safety | ||||
| Net Debt / EBITDA | 1.87 | 0.06 | -0.09 | -0.73 |
| Interest Coverage | 47.11 | -46.58 | 60.47 | 52.41 |
| Efficiency | ||||
| Inventory Turnover | 0.89 | 0.68 | 1.07 | 0.96 |
| Cash Conversion Cycle | 80.27 | 99.62 | 87.86 | 90.23 |